Evidence map›Paper›PMID 15711639›Full record

ArticleThe Journal of clinical investigation2005

IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.

Frank D Vladich, Susan M Brazille, Debra Stern, Michael L Peck, Raffaella Ghittoni, Donata Vercelli

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Single nucleotide polymorphisms of IL-13 and CD14 genes in allergic rhinitis: a meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. A Long Noncoding RNA "lnc"ed to Asthma Genetics.American journal of respiratory cell and molecular biology · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Frank D VladichFunctional Genomics Laboratory, Arizona Respiratory Center and Department of Cell Biology, College of Medicine, University of Arizona, Tucson, Arizona 85724, USA.
Susan M Brazille
Debra Stern
Michael L Peck
Raffaella Ghittoni
Donata Vercelli
University of Arizona · USUniversity of Siena · IT

Funding

HUMAN IL-13 GENE REGULATION AND IMPACT OF POLYMORPHISMSR01HL066391 · NHLBI · UNIVERSITY OF ARIZONA · PI VERCELLI, DONATA · 2000 to 2014
$5.0M
SNPs in transcriptional regulation of CD14P50HL067672 · NHLBI · UNIVERSITY OF ARIZONA · PI KLIMECKI, WALTER T. · 2002 to 2005
$5.0M
NHLBI NIH HHS P50 HL067672NHLBI NIH HHS P50 HL67672NHLBI NIH HHS R01 HL066391NHLBI NIH HHS R01 HL66391
6 · The paper itself

Abstract

Genetic factors are known to strongly influence susceptibility to allergic inflammation. The Th2 cytokine IL-13 is a central mediator of allergy and asthma, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13+2044GA is expected to result in the nonconservative replacement of arginine 130 (R130) with glutamine (Q). We examined the impact of IL13+2044GA on the functional properties of IL-13 by directly comparing the activity of WT IL-13 and IL-13 R130Q on primary human cells involved in the effector mechanisms of allergic inflammation. Our results show that IL-13 R130Q was significantly more active than WT IL-13 in inducing STAT6 phosphorylation and CD23 expression in monocytes and hydrocortisone-dependent IgE switching in B cells. Notably, IL-13 R130Q was neutralized less effectively than WT IL-13 by an IL-13R2 decoy. Decreased neutralization of the minor variant could contribute to its enhanced in vivo activity. Neither IL-13 variant was able to engage T cells, which suggests that increased allergic inflammation in carriers of IL13+2044A depends on enhanced IL-13-mediated Th2 effector functions rather than increased Th2 differentiation. Collectively, our data indicate that natural variation in the coding region of IL13 may be an important genetic determinant of susceptibility to allergy.

Indexed as

Polymorphism, Single NucleotideAnimalsAsthmaChlorocebus aethiopsCOS CellsHumansHypersensitivityImmunoglobulin EInflammationInterleukin-13MonocytesPhosphorylationReceptors, IgESTAT6 Transcription FactorTrans-ActivatorsImmunoglobulin EInterleukin-13Receptors, IgESTAT6 protein, humanSTAT6 Transcription FactorTrans-Activators

Identifiers

PMID15711639
PMCPMC548315
OpenAlexW2115331141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.